CIK 0001789769 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Instil Bio, Inc.
Sign in to watch- Ticker
- TIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 832072195
- Phone
- (972) 499-3350
- Business address
- 3963 MAPLE AVENUE, SUITE 350, DALLAS, TX, 75219
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-15 | McGaughy R Kent Jr Director | Other disposition | −260,323 | 8,218,467 | ||
| 2022-03-04 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-03-04 | Laumas Sandeep CFO and CBO | Grant or award · Employee Stock Option (right to buy) | +234,000 | 234,000 | ||
| 2022-03-04 | Roberts Zachary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +245,000 | $8.62 | $2.1M | 245,000 |
| 2022-03-04 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +750,000 | $8.62 | $6.5M | 750,000 |
| 2022-03-04 | Laumas Sandeep CFO and CBO | Grant or award · Employee Stock Option (right to buy) | +234,000 | $8.62 | $2.0M | 234,000 |
| 2022-03-04 | Chiruvolu Vijay Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +257,000 | $8.62 | $2.2M | 257,000 |
| 2021-10-07 | Roberts Zachary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 240,000 | ||
| 2021-09-10 | Roberts Zachary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2021-05-11 | Chiruvolu Vijay Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-05-11 | Roberts Zachary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-05-11 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2021-05-11 | Laumas Sandeep CFO and CBO | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-04-30 | Chiruvolu Vijay Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +154,237 | 154,237 | ||
| 2021-03-23 | Vivo Capital IX, LLC 10% owner | Conversion | +11,709,696 | 11,709,696 | ||
| 2021-03-23 | Vivo Capital IX, LLC 10% owner | Conversion | +477,091 | 12,186,787 | ||
| 2021-03-23 | Vivo Capital IX, LLC 10% owner | Purchase | +300,000 | $20.00 | $6.0M | 12,486,787 |
| 2021-03-23 | Vivo Capital IX, LLC 10% owner | Conversion · Series B Preferred Stock | −9,758,080 | 0 | ||
| 2021-03-23 | Vivo Capital IX, LLC 10% owner | Conversion · Series C Preferred Stock | −397,576 | 0 | ||
| 2021-03-23 | Shah Nimish P Director | Conversion | +5,100,866 | 5,100,866 |
Page 3 of 6 · 108 trades